CN103756940B - 偶发分枝杆菌及在发酵生产δ-内酯中的应用 - Google Patents
偶发分枝杆菌及在发酵生产δ-内酯中的应用 Download PDFInfo
- Publication number
- CN103756940B CN103756940B CN201410029845.3A CN201410029845A CN103756940B CN 103756940 B CN103756940 B CN 103756940B CN 201410029845 A CN201410029845 A CN 201410029845A CN 103756940 B CN103756940 B CN 103756940B
- Authority
- CN
- China
- Prior art keywords
- lactone
- liquid
- surplus
- peptone
- cctcc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000186365 Mycobacterium fortuitum Species 0.000 title claims abstract description 21
- 125000000422 delta-lactone group Chemical group 0.000 title abstract description 29
- 238000000855 fermentation Methods 0.000 title abstract description 19
- 230000004151 fermentation Effects 0.000 title abstract description 19
- 238000004519 manufacturing process Methods 0.000 title abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- 239000007788 liquid Substances 0.000 claims description 41
- 241000186359 Mycobacterium Species 0.000 claims description 34
- 230000001580 bacterial effect Effects 0.000 claims description 33
- 108010080698 Peptones Proteins 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 20
- 239000001888 Peptone Substances 0.000 claims description 20
- 239000008103 glucose Substances 0.000 claims description 20
- 235000019319 peptone Nutrition 0.000 claims description 20
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 18
- 241000894006 Bacteria Species 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 229940041514 candida albicans extract Drugs 0.000 claims description 11
- 239000012138 yeast extract Substances 0.000 claims description 11
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 10
- 239000002068 microbial inoculum Substances 0.000 claims description 10
- 238000011218 seed culture Methods 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- 239000002028 Biomass Substances 0.000 claims description 8
- 238000012262 fermentative production Methods 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 6
- 239000012092 media component Substances 0.000 claims description 4
- 238000007790 scraping Methods 0.000 claims description 4
- 238000004321 preservation Methods 0.000 abstract description 7
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 abstract description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract description 4
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 abstract description 4
- 229960005309 estradiol Drugs 0.000 abstract description 4
- 229930182833 estradiol Natural products 0.000 abstract description 4
- 229960003399 estrone Drugs 0.000 abstract description 4
- 239000012535 impurity Substances 0.000 abstract description 3
- 239000002609 medium Substances 0.000 description 53
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 38
- 230000000050 nutritive effect Effects 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 21
- 239000010410 layer Substances 0.000 description 19
- 239000000306 component Substances 0.000 description 16
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 16
- 238000000605 extraction Methods 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 230000001954 sterilising effect Effects 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 12
- 235000002378 plant sterols Nutrition 0.000 description 12
- 229910019142 PO4 Inorganic materials 0.000 description 11
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 11
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 11
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 11
- 239000010452 phosphate Substances 0.000 description 11
- 239000011591 potassium Substances 0.000 description 11
- 229910052700 potassium Inorganic materials 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 238000005070 sampling Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000007791 liquid phase Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 238000002703 mutagenesis Methods 0.000 description 9
- 231100000350 mutagenesis Toxicity 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000002054 inoculum Substances 0.000 description 8
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 8
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 8
- 239000004317 sodium nitrate Substances 0.000 description 8
- 229940001516 sodium nitrate Drugs 0.000 description 8
- 235000010344 sodium nitrate Nutrition 0.000 description 8
- 235000012424 soybean oil Nutrition 0.000 description 8
- 239000003549 soybean oil Substances 0.000 description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 229930182558 Sterol Natural products 0.000 description 7
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 7
- 239000004327 boric acid Substances 0.000 description 7
- 239000001110 calcium chloride Substances 0.000 description 7
- 229910001628 calcium chloride Inorganic materials 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 229910000365 copper sulfate Inorganic materials 0.000 description 7
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 7
- 235000007715 potassium iodide Nutrition 0.000 description 7
- 229960004839 potassium iodide Drugs 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 235000003702 sterols Nutrition 0.000 description 7
- 150000003432 sterols Chemical class 0.000 description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 7
- 229910000368 zinc sulfate Inorganic materials 0.000 description 7
- 229960001763 zinc sulfate Drugs 0.000 description 7
- 238000009825 accumulation Methods 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000001788 irregular Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 3
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 3
- 235000004420 brassicasterol Nutrition 0.000 description 3
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 description 3
- 235000019800 disodium phosphate Nutrition 0.000 description 3
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 3
- 230000003637 steroidlike Effects 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000187488 Mycobacterium sp. Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010812 external standard method Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XIIAYQZJNBULGD-UHFFFAOYSA-N (5alpha)-cholestane Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XIIAYQZJNBULGD-UHFFFAOYSA-N 0.000 description 1
- GKBHKNPLNHLYHT-UHFFFAOYSA-N 5beta-Stigmastan Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 GKBHKNPLNHLYHT-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241000934179 Meria <ascomycete> Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- XIIAYQZJNBULGD-LDHZKLTISA-N cholestane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XIIAYQZJNBULGD-LDHZKLTISA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- -1 delta-lactone steroid Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- GKBHKNPLNHLYHT-LWQAOISPSA-N stigmastane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 GKBHKNPLNHLYHT-LWQAOISPSA-N 0.000 description 1
- LAGFCVRVICMFFF-UHFFFAOYSA-N stigmastane Natural products CCC(CCC(C)C1CCC2C3CCC4CC(=O)CC(C)C4C3CCC12C)C(C)C LAGFCVRVICMFFF-UHFFFAOYSA-N 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
组分 | 用量 |
蛋白胨 | 5g/L |
牛肉膏 | 1.5g/L |
酵母膏 | 1.5g/L |
葡萄糖 | 5g/L |
氯化钠 | 5g/L |
琼脂 | 20g/L |
组分 | 用量 |
蛋白胨 | 0.5g/L |
牛肉膏 | 0.15g/L |
酵母膏 | 0.15g/L |
葡萄糖 | 0.5g/L |
氯化钠 | 0.5g/L |
实验序号 | 生物量 | 余量 |
20120806 | 0.50% | 培养基 |
20120807 | 0.70% | 培养基 |
20120808 | 1.0% | 培养基 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410029845.3A CN103756940B (zh) | 2014-01-22 | 2014-01-22 | 偶发分枝杆菌及在发酵生产δ-内酯中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410029845.3A CN103756940B (zh) | 2014-01-22 | 2014-01-22 | 偶发分枝杆菌及在发酵生产δ-内酯中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103756940A CN103756940A (zh) | 2014-04-30 |
CN103756940B true CN103756940B (zh) | 2015-05-13 |
Family
ID=50524267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410029845.3A Active CN103756940B (zh) | 2014-01-22 | 2014-01-22 | 偶发分枝杆菌及在发酵生产δ-内酯中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103756940B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104496958A (zh) * | 2014-11-28 | 2015-04-08 | 江西赣亮医药原料有限公司 | 一种膜法提取a环降解物的方法 |
CN105886418B (zh) * | 2014-12-01 | 2020-04-17 | 浙江神洲药业有限公司 | 偶发分枝杆菌在发酵生产表博醇中的应用 |
CN108138126B (zh) * | 2016-06-16 | 2021-09-03 | 华东理工大学 | 一种分枝杆菌基因工程菌及其在制备甾体化合物中的应用 |
CN110699398B (zh) * | 2019-10-16 | 2023-04-28 | 湖南新合新生物医药有限公司 | 一种静息细胞转化植物甾醇制备a环降解物的方法 |
CN110643649B (zh) * | 2019-10-16 | 2023-04-28 | 湖南新合新生物医药有限公司 | 一种生长细胞转化植物甾醇制备a环降解物的方法 |
CN111500498B (zh) * | 2020-04-30 | 2023-10-20 | 沈阳博泰生物制药有限公司 | 一种新金分枝杆菌及其用途 |
CN114920793B (zh) * | 2022-06-01 | 2023-08-08 | 贵州大学 | 含异丙醇胺亚结构的雌酚酮类化合物,制备方法,组合物及用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042459A (en) * | 1975-11-17 | 1977-08-16 | The Upjohn Company | Composition of matter and process |
CN1670185A (zh) * | 2005-03-03 | 2005-09-21 | 上海来益生物药物研究开发中心有限责任公司 | 一种偶发分枝杆菌及在微生物转化生产睾酮中的应用 |
-
2014
- 2014-01-22 CN CN201410029845.3A patent/CN103756940B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042459A (en) * | 1975-11-17 | 1977-08-16 | The Upjohn Company | Composition of matter and process |
CN1670185A (zh) * | 2005-03-03 | 2005-09-21 | 上海来益生物药物研究开发中心有限责任公司 | 一种偶发分枝杆菌及在微生物转化生产睾酮中的应用 |
Non-Patent Citations (2)
Title |
---|
偶发分枝杆菌MF2和MF96生物转化差异的机理研究;凌良飞 等;《微生物学报》;20051231;第45卷(第4期);526-529 * |
微生物发酵降解植物甾醇侧链生产17-酮甾体研究进展;杨顺楷 等;《生物加工过程》;20101231;第8卷(第5期);69-77 * |
Also Published As
Publication number | Publication date |
---|---|
CN103756940A (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103756940B (zh) | 偶发分枝杆菌及在发酵生产δ-内酯中的应用 | |
CN103382445B (zh) | 用于制备雄烯二酮的微生物菌株及其应用 | |
CN103898004B (zh) | 假诺卡氏菌及其发酵生产骨化二醇的方法 | |
CN104531538A (zh) | 三孢布拉霉突变株及其应用 | |
CN105112476A (zh) | 一种发酵生产脂肽类生物表面活性剂的方法 | |
CN104694601A (zh) | 一种高效制备伊枯草菌素a及其同系物的方法 | |
CN103740799B (zh) | 一种生物转化植物甾醇制备甾体药物中间体的方法 | |
CN104694401A (zh) | 纯绿青霉菌株及用其生产麦角甾醇过氧化物的方法 | |
CN105886418B (zh) | 偶发分枝杆菌在发酵生产表博醇中的应用 | |
CN102876582B (zh) | 金龟子绿僵菌突变株及其在甾体化合物羟化反应中的应用 | |
CN102965288A (zh) | 一株生物合成3β,7α,15α-三羟基雄甾-5-烯-17-酮的菌株及其应用 | |
CN102127511A (zh) | 一株斜卧青霉及其培养方法与在转化甾体药物中的应用 | |
CN109680032A (zh) | 一种利用微生物合成7,21-二羟基-20-甲基孕甾-4-烯-3-酮的方法 | |
CN1322112C (zh) | 一种偶发分枝杆菌及在微生物转化生产睾酮中的应用 | |
CN106987542A (zh) | 一株简单节杆菌突变株在1,2位脱氢中的应用 | |
CN117106595A (zh) | 一株产黄酮类化合物的工业大麻内生真菌hmy07及其应用 | |
CN104694609A (zh) | 一种植物甾醇转化为雄烯二酮转化效率的提高方法 | |
CN105505798A (zh) | 一种产麦角甾醇内生真菌及其应用 | |
CN105385608A (zh) | 一种香菇液体菌种深层发酵工艺 | |
CN115896179A (zh) | 一种极端从毛红曲霉菌利用酿酒废水生产高附加值产物的方法 | |
CN113817614B (zh) | 一种高效合成c21甾体苷的胶孢炭疽菌z-44及其应用 | |
CN109251870A (zh) | 一种新金色分枝杆菌突变株及其在制备hip的应用 | |
Zhu et al. | Fluid flow induced shear stress affects cell growth and total flavone production by Phellinus igniarius in stirred-tank bioreactor | |
CN103484375A (zh) | 一株能生物合成睾内酯的尖孢镰刀菌及合成方法 | |
CN113881602A (zh) | 一种高产c21甾体化合物的蜡样芽孢杆菌x-32及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211230 Address after: 415400 Hongxiang Road, Jiashan industrial new area, Jinshi City, Changde City, Hunan Province Patentee after: HUNAN LONGTENG BIOTECHNOLOGY Co.,Ltd. Address before: 415400 Jiashan New Industrial Zone, Jin City, Changde City, Hunan Province Patentee before: HUNAN XINHEXIN BIOLOGICAL MEDICINE Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 415400 Hongxiang Road, Jiashan industrial new area, Jinshi City, Changde City, Hunan Province Patentee after: Hunan Xinhexin Biotechnology Co.,Ltd. Country or region after: China Address before: 415400 Hongxiang Road, Jiashan industrial new area, Jinshi City, Changde City, Hunan Province Patentee before: HUNAN LONGTENG BIOTECHNOLOGY Co.,Ltd. Country or region before: China |